Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000150334 | SCV000197436 | benign | not specified | 2014-04-24 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000150334 | SCV000224840 | benign | not specified | 2014-09-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000390508 | SCV000466509 | likely benign | Cystic fibrosis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000515121 | SCV000610226 | likely benign | not provided | 2017-08-16 | criteria provided, single submitter | clinical testing | |
CFTR- |
RCV000390508 | SCV001169202 | benign | Cystic fibrosis | 2018-01-29 | criteria provided, single submitter | curation | the variant does not result in CFTR-RD neither |
Ambry Genetics | RCV001172256 | SCV001170541 | likely benign | Inborn genetic diseases | 2018-11-06 | criteria provided, single submitter | clinical testing | Intact protein function observed by in vitro/ex vivo assays;Intronic alteration with no splicing impact by rt-pcr analysis or other splicing assay;Other strong data |
Invitae | RCV000390508 | SCV001717927 | benign | Cystic fibrosis | 2021-12-18 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000515121 | SCV002058053 | benign | not provided | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000150334 | SCV002518199 | benign | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000390508 | SCV001652693 | not provided | Cystic fibrosis | no assertion provided | literature only | The severity of lung disease in individuals heterozygous or homozygous for p.Arg117His depends on the presence of a variation in the poly T tract of intron 9, c.1210-12T[5_9] [Massie et al 2001]. Individuals with a CF-causing variant plus the 5T variant in cis with p.Arg117His usually develop the lung disease of CF, but those individuals with p.Arg117His and the 7T variant or the 9T variant have a highly variable phenotype that can range from no symptoms to mild lung disease [Kiesewetter et al 1993, Chmiel et al 1999]. | |
Genome Diagnostics Laboratory, |
RCV000515121 | SCV002034270 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000515121 | SCV002034896 | likely benign | not provided | no assertion criteria provided | clinical testing |